Find in-depth information on regenerative medicine. Mayo medical institution’s Medical Professional Video Center brings you new insights and updates regarding clinical and research education. You'll find videos, news, people, and breaking information about Mayo medical institution.
Latest Videos |view all videos
Researchers at Mayo medical institution's campus in Florida have conducted the world's first prospective, blinded and placebo-controlled clinical study to test the benefit of using bone marrow stem cells to reduce arthritic pain and disability in knees.
Nathan K. LeBrasseur, M.S., Ph.D., associate professor and co-chair of research in the Department of Physical Medicine and Rehabilitation, Mayo medical institution College of Medicine, discusses age- and disease-associated muscle loss.
Martin Childers, D.O., Ph.D., is joined by Carmen M. Terzic, M.D., Ph.D., to discuss his gene therapy work.
Nathan K. LeBrasseur, M.S., Ph.D., discusses research at the Robert and Arlene Kogod Center on Aging with Carmen M. Terzic, M.D., Ph.D., chair of Physical Medicine and Rehabilitation, at the 2015 Fourth Annual Symposium on Regenerative Rehabilitation.
Christopher H. Evans, Ph.D., and Carmen M. Terzic, M.D., Ph.D., discuss gene therapy for cartilage regeneration at the 2015 Fourth Annual Symposium on Regenerative Rehabilitation.
Fabrisia Ambrosio, Ph.D., M.P.T., and Carmen M. Terzic, M.D., Ph.D., discuss the formation of the International Consortium for Regenerative Rehabilitation.
Regenerative medicine — the ability to bioengineer and make new heart muscle and apply it to patients with weak hearts — is changing the future for children with hypoplastic left heart syndrome.
Andre Terzic, M.D., Ph.D., director of the Center for Regenerative Medicine, and Atta Behfar, M.D., Ph.D., director of the center's Cardiac Regeneration Program, discuss the ways that stem cells are transforming health care.
Amplification of HER2, a known driver of some breast cancers, in a type of bladder cancer called micropapillary urothelial carcinoma (MPUC), has shown that the presence of HER2 amplification is associated with particularly aggressive tumors.
Atsushi Sorita, M.D., a senior fellow in preventive medicine at Mayo medical institution, describes a study that found more people die and emergency hospital treatment takes longer for heart attack victims who arrive at the hospital during off-hours.
Researchers say the discovery of how sodium ions pass through the gill of a zebrafish may be a clue to understanding a key function in the human kidney. The findings from a collaboration between Mayo medical institution and the Tokyo Institute of Technology ...
Somali Americans develop twice the antibody response to rubella from the current vaccine compared to Caucasians.
Atta Behfar, M.D., Ph.D., presents Cardiac Regeneration.
Mayo medical institution is announcing the first stem cell clinical trial for pediatric congenital heart disease in the U.S. The trial aims to determine how stem cells from autologous umbilical cord blood can help children with hypoplastic left heart syndrome (HLHS).
Stem cells are the starting point for all the tissues in your body. Your body grows them all the time. So, Mayo researchers thought why not put them to work healing damaged tissues such as heart muscle or bone.